Safety and effectiveness of ruxolitinib in real-world patients with myelofibrosis: A 2-year observational study from Taiwan.
Journal
Leukemia research
Journal Volume
147
ISSN
1873-5835
Date Issued
2024-12
Author(s)
Kuo, Ming-Chung
Lin, Hsuan-Yu
Gau, Jyh-Pyng
Wang, Ming-Chung
Chang, Ming-Chih
Chen, Tsung-Chih
Yeh, Shih-Peng
Chen, Yeu-Chin
Huang, Cih-En
Chiang, I-Ju
Cheng, Hao-Wei
Lee, Yee-Ming
Ku, Fan-Chen
Chang, Cheng-Shyong
DOI
10.1016/j.leukres.2024.107601
Subjects
Myelofibrosis
Pneumonia
Real-world
Ruxolitinib
Taiwan
SDGs
Publisher
Elsevier Ltd
Description
Article number 107601
Type
letter